SORAYA: Mirvetuximab Soravtansine in FRα-High Platinum-Resistant Ovarian Cancer Last updated on Jun 5, 2026 Previous GOG 85: Cisplatin/5-FU vs Hydroxyurea with Radiation in Locally Advanced Cervical Cancer Next ICON4/AGO-OVAR-2.2: Paclitaxel–Platinum vs Platinum in Platinum-Sensitive Relapsed Ovarian Cancer
